Average Co-Inventor Count = 2.43
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. American Cyanamid Company (42 from 3,580 patents)
2. Wyeth Holdings Corporation (8 from 113 patents)
3. Wyeth (6 from 1,309 patents)
4. American Home Products Corporation (3 from 1,567 patents)
5. Other (1 from 832,680 patents)
6. Immunex Corporation (1 from 451 patents)
7. Max-planck-institute for Biochemistry (1 from 1 patent)
60 patents:
1. 7595327 - Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase
2. 7576222 - Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
3. 7488754 - Method for the treatment of polycystic kidney disease
4. 7485667 - Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors
5. 7420001 - Biaryl sulfonamides and methods for using same
6. 7199155 - Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors
7. 7179911 - Method for preparing hydroxamic acids
8. 6946473 - Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
9. 6842704 - Crystalline TNF-α-converting enzyme and uses thereof
10. 6825354 - Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TACE inhibitors
11. 6812227 - Acetylenic &agr;-amino acid-based sulfonamide hydroxamic acid tace inhibitors
12. 6762178 - Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
13. 6753337 - Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
14. 6716833 - Acetylenic &agr;-amino acid-based sulfonamide hydroxamic acid tace inhibitors
15. 6548524 - Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors